UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000024182
Receipt number R000027531
Scientific Title Effects of calcium supplementation on bone mineral density in milk allergy children
Date of disclosure of the study information 2016/09/27
Last modified on 2019/09/30 09:48:23

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of calcium supplementation on bone mineral density in milk allergy children

Acronym

Effects of calcium supplementation on bone mineral density in milk allergy children

Scientific Title

Effects of calcium supplementation on bone mineral density in milk allergy children

Scientific Title:Acronym

Effects of calcium supplementation on bone mineral density in milk allergy children

Region

Japan


Condition

Condition

cow's milk allergy

Classification by specialty

Pediatrics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate bone mineral density in children with cow's milk allergy.
To assess the effects of calcium or calcium and vitamine D supplementation on bone mineral density, and safety of them.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

bone mineral density

Key secondary outcomes

urinary calcium/creatinine ratio


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

calcium 260 mg/day (as 2 g calcium lactate/day) for 12 months

Interventions/Control_2

calcium 260 mg/day(as 2 g calcium lactate/day) plus 1 alpha(OH)D3 0.25 microgram/day for 12 months

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

8 years-old <=

Age-upper limit

15 years-old >=

Gender

Male and Female

Key inclusion criteria

IgE-mediated cow's milk allergy

Key exclusion criteria

1.has complication as follows
1)Steroid-induced osteoporosis
2)osteogenesis imperfecta
3)Precocious puberty
4)other disease affecting calcium metabolism
2.Has taken following medications effected to calcium absorption and elimination before dosing
3.taking digitalis(contraindicated drug)
4.Ineligible patients according to the investigator's judgment

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Mika
Middle name
Last name Ogata

Organization

National Hospital Organization Kumamoto Medical Center

Division name

Department of Pediatrics

Zip code

8600008

Address

1-5 Ninomaru Chuo-ku Kumamoto-city

TEL

096-353-6501

Email

mikaoga@kumamed.jp


Public contact

Name of contact person

1st name Mika
Middle name
Last name Ogata

Organization

National Hospital Organization Kumamoto Medical Center

Division name

Department of Pediatrics

Zip code

8600008

Address

1-5 Ninomaru Chuo-ku Kumamoto-city

TEL

096-353-6501

Homepage URL


Email

mikaoga@kumamed.jp


Sponsor or person

Institute

National Hospital Organization Kumamoto Medical Center

Institute

Department

Personal name



Funding Source

Organization

Japan Dairy Association
Japan Milk Academic Alliance
Dairy Products Health Science Council

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor

Jikei Hospital

Name of secondary funder(s)



IRB Contact (For public release)

Organization

National Hospital Organization Kumamoto Medical Center

Address

1-5 Ninomaru Chuo-ku Kumamoto-city

Tel

0963536501

Email

idera.kazuyuki.sg@mail.hosp.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

国立病院機構熊本医療センター小児科(熊本県)
医療法人聖粒会 慈恵病院小児科(熊本県)


Other administrative information

Date of disclosure of the study information

2016 Year 09 Month 27 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2016 Year 04 Month 01 Day

Date of IRB


Anticipated trial start date

2016 Year 07 Month 01 Day

Last follow-up date

2017 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 09 Month 27 Day

Last modified on

2019 Year 09 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027531


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name